维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Engel SS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Sitagliptin more effec- tively achieves a composite endpoint for A1C reduction, lack of hypogly- cemia and no body weight gain compared with glipizide 显示文摘	Seek TL Engel SS Williams-Herman DE	2011	Diabetes Res Clin Pract2011，93，1：	1
2	Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies显示文摘	Engel SS Round E Golm GT	2013	Diabetes Ther2013，4，1：	1
3	Safety and tolerability of sitagliptin in type 2 diabetes:pooled analysis of 25 clinical studies显示文摘	Engel SS Round E Golm GT		0，，01：	1
4	Assessment of AACE/ACE recommendations for initial dual antihyperglycemic therapy using the fixed-dose combination of sitagliptin and metformin versus metformin 显示文摘	Engel SS Seck TL Golm GT	2013	Endocr Pract2013，19，5：	1
5	Early combination therapy for the treatment of type 2 diabetes mellitus:systematic review and meta-analysis显示文摘	Phung OJ Sobieraj DM Engel SS	2014	Diabetes Obes Metab2014，16，5：	1
6	lnitial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes 显示文摘	Wainstein J Katz L Engel SS	2012	Diabetes Obes Metab2012，14，5：	1
7	Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes 显示文摘	Williams-Herman D Engel SS Round E	2010	BMC Endocr Disord2010，10，：	1
8	Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes显示文摘	Wainstein J Katz L Engel SS	2012	Diabetes Obes Metab2012，14，5：	1
9	Safety and tolerability of sitagliptin in clinical studies: a pooled analy- sis of data from 10,246 patients with type 2 diabetes显示文摘	Williams-Herman D Engel SS Round E	2010	B M C Endocr Disord2010，10，：	1
10	Safety and toler- ability of sitagliptin in clinical studies : a pooled analysis of data from 10,246 patients with type 2 diabetes 显示文摘	Williams-Herman D Engel SS Round E	2010	BMC Endocr Disord2010，，10：	1
11	Safety and tolembility of sitagliptin in clinical studies: a pooled analysis of data from 10246 patients with type 2 diabetes 显示文摘	Williams-Herman D Engel SS Round E	2010	BMC Endocr Disord2010，10，：	1
12	Safety and tolerability ofsitagliptin in clinical studies: a pooled analysis of data from 10,246 patientswith type 2 diabetes显示文摘	Williams-Herman D Engel SS Round E	2010	BMC endocrine Disorders2010，10，1：	1
13	Indomethacin as an analgesic after hysterectomy显示文摘	Engel C Lund B Kristensen SS	1989	Acta Anaesthesiol Scand1989，33，6：	1
14	Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus:a pooled analysis显示文摘	Engel SS Golin GT Shapiro D	2013	Cardiovasc Diabetol2013，12，：	1
15	Safety and tolerability of sitagliptin in clinical studies:a pooled analysis of data from 10,246patients with type 2 diabetes显示文摘	Williams-Herman D Engel SS Round E		0，，：	1
16	Assessment of AACE/ ACE recommendations for initial dual antihyperglycemic thera- py using the fixed-dose combination of sitagliptin and met- formin versus metformin 显示文摘	Engel SS Seck TL Golm GT	2013	Endocr Pract2013，19，5：	1
17	Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes显示文摘	Williams-Herman D Engel SS Round E	2010	BMC Endocr Disord2010，10，：	1
18	Safety and tolerability ofsitagliptin in type 2 diabetes : pooled analysis of 25 clinical stud-ies显示文摘	Engel SS Round E Golm GT	2013	Diabetes Ther2013，4，1：	1
19	Safety and tolerability of sitagliptin in clinical studies:a pooled analysis of data from 10,246patients with type 2 diabetes显示文摘	Williams-Herman D Engel SS Round E		0，，：	1
20	Sitagliptin:review of preclinical and clinical data regarding incidence of pancreatitis显示文摘	Engel SS Williams-Herman DE Golm GT		0，，07：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示